Angiography XR

Angiography XR Market Outlook

The global Angiography XR market is projected to reach USD 5.8 billion by 2035, with a compound annual growth rate (CAGR) of 6.7% from 2025 to 2035. This promising growth trajectory can be attributed to the increasing prevalence of cardiovascular diseases and the rising demand for minimally invasive surgical procedures. Additionally, advancements in imaging technologies and the integration of artificial intelligence in angiography systems are expected to enhance diagnostic accuracy and patient outcomes, further driving the market's expansion. Furthermore, the growing geriatric population, which is more susceptible to vascular diseases, combined with rising healthcare expenditure, is anticipated to create a robust demand for angiography XR solutions. As healthcare systems continue to evolve, the focus on early detection and accurate diagnosis of vascular conditions will also bolster market growth opportunities.

Growth Factor of the Market

The growth of the Angiography XR market is significantly influenced by various factors, including the increasing incidence of lifestyle-related diseases such as obesity, hypertension, and diabetes, which are major contributors to cardiovascular disorders. Additionally, the technological advancements in imaging modalities, such as the introduction of 3D imaging and high-resolution scanners, have enhanced the effectiveness of angiography procedures, making them more appealing to healthcare providers. The shift towards patient-centric healthcare, which emphasizes quicker recovery times and less invasive procedures, is also propelling the demand for angiography XR technologies. Moreover, supportive governmental initiatives to improve healthcare infrastructure and promote early diagnosis of diseases are acting as catalysts for market growth. The rising awareness regarding the benefits of early intervention in vascular diseases is further driving the demand for advanced angiographic solutions across various healthcare settings.

Key Highlights of the Market

• The market is expected to grow at a CAGR of 6.7% from 2025 to 2035.
• Technological advancements in imaging modalities are enhancing diagnostic capabilities.
• Rising prevalence of cardiovascular diseases is driving demand for angiography XR solutions.
• Supportive healthcare policies are promoting early diagnosis and treatment.
• The trend towards minimally invasive procedures is encouraging market growth.

By Product Type

Catheter Angiography:

Catheter Angiography remains one of the most widely used techniques in the Angiography XR market due to its effectiveness in visualizing blood vessels and diagnosing vascular diseases. This technique involves the insertion of a catheter into the blood vessels, allowing for the direct delivery of contrast agents to specific areas, thereby enhancing the imaging quality. The ability of catheter angiography to provide real-time imaging and its high sensitivity to detect abnormalities such as blockages and stenosis make it a preferred choice among healthcare professionals. Furthermore, advancements in catheter design and imaging systems have improved patient safety and reduced procedural risks, contributing to the sustained demand for this product type in hospitals and diagnostic centers worldwide.

CT Angiography:

CT Angiography has gained popularity in recent years due to its non-invasive nature and ability to produce detailed three-dimensional images of the blood vessels. This imaging technique employs computed tomography to acquire images, which are then processed to provide a comprehensive view of vascular structures. Its quick execution and reduced need for patient sedation have made it increasingly favorable in emergency settings. As technology continues to evolve, enhancements in CT scanners, including faster acquisition times and improved image quality, are expected to further propel the adoption of CT Angiography in clinical practices. This product type is particularly beneficial for patients with renal insufficiency, as it reduces the risk of complications associated with traditional catheter-based angiography methods.

MR Angiography:

MR Angiography, or Magnetic Resonance Angiography, offers a safe and effective alternative to traditional angiography methods, particularly for patients with allergies to iodinated contrast agents. Utilizing magnetic resonance imaging technology, MR Angiography provides high-resolution images of blood vessels without the use of ionizing radiation. Its ability to differentiate between various types of tissue and visualize complex vascular structures makes it especially useful in diagnosing conditions such as aneurysms and vascular malformations. The market for MR Angiography is increasingly driven by the growing awareness of the risks associated with radiation exposure and the rising demand for safer diagnostic procedures. Additionally, advancements in MRI technology and contrast agents are expected to enhance the diagnostic capabilities of MR Angiography, making it a vital component of the angiography XR market.

Digital Subtraction Angiography:

Digital Subtraction Angiography (DSA) is a specialized imaging technique that allows for the clear visualization of blood vessels by digitally subtracting the background structures from the images. This method is particularly effective in identifying vascular lesions, stenosis, and other abnormalities. DSA has become an essential tool in interventional radiology and minimally invasive procedures, as it provides real-time imaging capabilities during interventions. The growing preference for minimally invasive techniques drives the demand for DSA, as it is associated with shorter recovery times and reduced complication rates. Moreover, continuous advancements in image processing technologies are enhancing the quality and accuracy of DSA images, ensuring its relevance in contemporary clinical practices.

Others:

The "Others" category encompasses various angiography techniques that contribute to the overall market, such as ultrasound-based angiography and hybrid imaging systems that combine multiple modalities. These techniques are gaining traction as healthcare providers seek comprehensive diagnostic solutions that address specific patient needs. Innovations in ultrasound technology, for instance, enable real-time imaging and dynamic assessment of blood flow, making it a valuable tool in vascular diagnostics. Additionally, hybrid systems that integrate different imaging modalities are becoming increasingly popular for their ability to provide multi-faceted insights into vascular health. As the demand for personalized and accurate diagnostic approaches rises, the "Others" segment is expected to witness substantial growth in the coming years.

By Application

Diagnosis:

Diagnosis is one of the primary applications of the Angiography XR market, as it plays a crucial role in identifying vascular diseases and conditions. Healthcare providers utilize various angiographic techniques to diagnose conditions such as coronary artery disease, peripheral artery disease, and neurovascular disorders. The ability of angiography to provide detailed images of blood vessels enables clinicians to detect blockages, abnormalities, and other vascular issues with high precision. As the demand for early diagnosis and effective treatment options grows, the significance of angiography in diagnostic procedures continues to rise. Additionally, advancements in imaging technology are further enhancing the diagnostic capabilities, leading to improved patient outcomes and reduced hospital stay durations.

Research:

The research application of the Angiography XR market involves the use of angiographic techniques in clinical studies and trials aimed at understanding vascular diseases better and developing new therapeutic approaches. Researchers rely on angiography to gather essential data regarding blood flow, vascular anatomy, and the effectiveness of various treatment modalities. The increasing focus on innovative research and development initiatives in the healthcare sector is propelling the demand for angiographic imaging in academia and pharmaceutical research environments. Additionally, partnerships between research institutions and healthcare providers are fostering advancements in angiography techniques, thereby enhancing their utility in clinical research settings. The growing emphasis on evidence-based practices in medicine is further elevating the importance of angiography in research applications.

Treatment:

Treatment applications of Angiography XR encompass interventional procedures that utilize angiographic imaging for guiding therapeutic interventions. Conditions such as atherosclerosis, aneurysms, and vascular malformations often require angioplasty, stenting, or embolization, which are facilitated by real-time imaging provided by angiography techniques. The increasing preference for minimally invasive procedures among patients and healthcare providers is driving the demand for angiography applications in treatment settings. Furthermore, technological advancements, such as the integration of robotics and AI in angiography systems, are enhancing procedural efficiency and accuracy. As the healthcare landscape continues to evolve towards personalized treatment approaches, the importance of angiography in therapeutic applications is expected to grow significantly.

By End User

Hospitals:

Hospitals represent a significant segment of the Angiography XR market, as they are the primary providers of diagnostic and interventional angiographic services. The increasing number of hospital admissions related to cardiovascular diseases and the rising demand for advanced imaging services are driving the growth of this segment. Hospitals are investing in state-of-the-art angiography systems to improve diagnostic accuracy and enhance patient outcomes. Moreover, the presence of specialized cardiovascular units and interventional radiology departments within hospitals is further boosting market demand. As the healthcare sector continues to prioritize early detection and treatment of vascular conditions, hospitals are likely to remain at the forefront of angiography service delivery.

Diagnostic Centers:

Diagnostic centers are becoming increasingly pivotal in the Angiography XR market, as they offer specialized imaging services to patients referred by healthcare providers. These centers are equipped with advanced angiographic technologies that enable accurate diagnosis and timely intervention for vascular disorders. The growing trend of outpatient services and the rising preference for cost-effective diagnostic options are driving the demand for angiography services in diagnostic centers. Additionally, these facilities often collaborate with hospitals, providing essential imaging support for surgical planning and follow-up care. As the need for accessible and efficient diagnostic services continues to grow, diagnostic centers are expected to contribute significantly to the expansion of the angiography XR market.

Research Institutes:

Research institutes play a crucial role in advancing the Angiography XR market by conducting studies aimed at improving angiographic techniques and exploring innovative applications. These institutions are often at the forefront of developing new imaging technologies and methodologies that enhance the understanding of vascular diseases. Collaborations between research institutes and healthcare providers facilitate the translation of research findings into clinical practice, further driving the demand for angiography in academic settings. As the focus on research and development in the healthcare sector intensifies, research institutes are expected to continue influencing the growth of the angiography XR market significantly.

Others:

The "Others" segment encompasses various end users, including specialized clinics, outpatient facilities, and long-term care centers that utilize angiography for diagnostic and treatment purposes. These facilities are increasingly adopting advanced angiographic techniques to enhance their service offerings and improve patient care. The growth of outpatient surgical centers, in particular, is driving demand for angiography solutions, as they often focus on providing minimally invasive procedures. Moreover, as healthcare systems evolve to prioritize accessible and efficient care, the adoption of angiographic services in various healthcare settings is expected to rise, contributing to the overall growth of the angiography XR market.

By Indication

Coronary Artery Disease:

Coronary Artery Disease (CAD) is one of the leading causes of morbidity and mortality worldwide, making it a significant indication for angiography procedures. Angiographic techniques are essential for diagnosing CAD, as they allow healthcare providers to visualize the coronary arteries and assess the severity of blockages or lesions. The increasing prevalence of risk factors such as obesity, hypertension, and diabetes is contributing to the growing incidence of CAD, thereby driving the demand for angiography services. Furthermore, as advancements in imaging technologies enhance the accuracy and efficiency of CAD diagnosis, the reliance on angiography procedures is expected to continue increasing, further elevating its importance in the angiography XR market.

Peripheral Artery Disease:

Peripheral Artery Disease (PAD) is another significant indication for angiographic procedures, characterized by narrowed arteries that restrict blood flow to the limbs. The growing prevalence of PAD, often associated with aging and lifestyle factors, highlights the critical need for accurate diagnostic tools. Angiography plays a vital role in assessing the severity and extent of arterial blockages in patients with PAD, allowing for timely intervention and management strategies. As awareness of PAD increases and the demand for effective treatment options grows, angiography is expected to remain a key component in the diagnosis and management of this condition, driving market growth in the coming years.

Neurovascular Disease:

Neurovascular diseases, including conditions such as aneurysms and arteriovenous malformations, represent a critical indication for angiographic imaging. These conditions require precise visualization of the vascular structures within the brain to facilitate accurate diagnosis and treatment planning. Angiography is crucial for detecting and monitoring neurovascular diseases, as it provides detailed images that aid in determining the appropriate therapeutic approach. The rising incidence of neurovascular diseases, coupled with advancements in angiographic technologies, is expected to drive demand in this indication segment. As the understanding of neurovascular conditions continues to evolve, the role of angiography in their management is becoming increasingly vital.

Others:

The "Others" category includes various other indications for angiography, such as vascular malformations, thoracic outlet syndrome, and more. These conditions highlight the versatility of angiographic techniques in diagnosing a wide range of vascular issues. The demand for angiography services in these indications is supported by the increasing recognition of the importance of early diagnosis and intervention in enhancing patient outcomes. Furthermore, advancements in imaging technology are improving the ability to diagnose and treat diverse vascular conditions, thereby expanding the applications of angiography across various medical specialties. As healthcare continues to evolve, the significance of angiography in addressing various indications is expected to grow.

By Region

North America dominates the Angiography XR market, accounting for approximately 43% of the overall market share in 2025. This leadership position is largely attributed to the presence of advanced healthcare infrastructure, high adoption rates of cutting-edge medical technologies, and a significant prevalence of cardiovascular diseases among the population. The region's emphasis on early diagnosis and treatment, combined with increasing healthcare expenditure, further bolsters the demand for angiography services. Additionally, favorable reimbursement policies in the U.S. and Canada are encouraging healthcare providers to invest in advanced angiography technologies. The CAGR for North America is projected to be around 6.2% from 2025 to 2035, reflecting its strong growth potential in the coming years.

Europe holds the second-largest share in the Angiography XR market, contributing approximately 29% to the global market in 2025. The increasing aging population and the rising prevalence of cardiovascular and neurovascular diseases are significant factors driving market growth in this region. Moreover, European countries are actively investing in healthcare technologies to improve patient outcomes and streamline diagnostic processes. The region is expected to witness a CAGR of 7.1% during the forecast period from 2025 to 2035, driven by advancements in imaging technologies and a growing emphasis on research and development initiatives among healthcare providers.

Opportunities

The Angiography XR market presents numerous opportunities for growth as technological advancements continue to reshape the healthcare landscape. One of the most promising opportunities lies in the development and integration of artificial intelligence and machine learning algorithms in angiographic imaging systems. These technologies have the potential to enhance image quality, automate image analysis, and improve diagnostic accuracy, ultimately leading to better patient outcomes. Additionally, the shift towards telemedicine and remote monitoring solutions presents a significant opportunity for angiography providers to expand their services and reach a wider patient population. By leveraging telehealth platforms, healthcare organizations can facilitate remote consultations and follow-up assessments, thereby improving access to angiography services in underserved communities.

Furthermore, the increasing focus on preventive healthcare and early diagnosis of vascular diseases creates a ripe environment for market growth. Healthcare providers are recognizing the value of early intervention in managing cardiovascular and neurovascular conditions, thereby driving demand for angiography services. The rising investment in healthcare infrastructure, particularly in emerging economies, also presents lucrative opportunities for market players to expand their footprint and introduce innovative angiography solutions. As healthcare continues to evolve, the ability to adapt and integrate new technologies into angiographic practices will be crucial for capitalizing on these emerging opportunities within the market.

Threats

Despite the promising growth prospects for the Angiography XR market, several threats could potentially hinder its development. One of the primary concerns is the rising cost of advanced imaging technologies, which may limit accessibility for healthcare providers, particularly in resource-constrained settings. As medical devices become increasingly complex and technologically advanced, the associated costs can deter smaller healthcare facilities from investing in angiography systems. Additionally, the evolving regulatory landscape poses a challenge for manufacturers, as they must navigate stringent approval processes and ensure compliance with safety and quality standards. These factors could slow down the adoption of angiography technologies, particularly in emerging markets where budget constraints are more pronounced.

Moreover, the ongoing concern regarding radiation exposure associated with certain angiographic procedures may also impact market growth. Although many modern angiography techniques are designed to minimize radiation doses, public apprehension surrounding the safety of these procedures can deter patients from seeking necessary diagnostic and treatment interventions. Compounding this issue is the growing competition among various imaging modalities, such as ultrasound and MRI, which may offer less invasive options for vascular assessment. As healthcare providers and patients become more conscious of the risks associated with traditional angiography methods, addressing these concerns will be essential for sustaining market growth.

Competitor Outlook

• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Canon Medical Systems
• Medtronic Plc
• Baxter International Inc.
• Cardinal Health Inc.
• Boston Scientific Corporation
• Johnson & Johnson
• Hitachi Ltd.
• Fujifilm Holdings Corporation
• Hologic Inc.
• Varian Medical Systems
• Samsung Medison Co., Ltd.
• Shimadzu Corporation

The competitive landscape of the Angiography XR market is characterized by the presence of several key players who are striving to enhance their product offerings and maintain a competitive edge. Major companies such as GE Healthcare, Siemens Healthineers, and Philips Healthcare dominate the market, leveraging their extensive research and development capabilities to innovate and improve their angiography systems. These companies are focusing on integrating advanced imaging technologies, such as artificial intelligence and 3D visualization, into their products to enhance diagnostic accuracy and streamline workflows in clinical settings. As competition intensifies, these firms are also investing in strategic partnerships and collaborations to expand their market reach and capitalize on emerging opportunities.

In terms of specific companies, GE Healthcare is recognized for its comprehensive portfolio of angiography solutions, including advanced fluoroscopy systems and hybrid operating rooms designed for minimally invasive procedures. The company actively invests in research and development to enhance the performance of its imaging systems, ensuring they meet the evolving needs of healthcare providers. Siemens Healthineers, on the other hand, is known for its innovative imaging technologies, such as the Artis series of angiography systems that offer exceptional image quality and real-time visualization capabilities. The company's commitment to advancing angiographic techniques through technological innovation positions it well for sustained growth in the market.

Philips Healthcare, a leader in medical imaging, is also making significant strides in the angiography space with its advanced imaging solutions that prioritize patient safety and comfort. The company has been at the forefront of developing next-generation angiography systems that integrate AI-driven analytics for improved diagnostic capabilities. Other players, such as Canon Medical Systems and Medtronic, are focusing on expanding their product lines and enhancing their angiography technologies to cater to the increasing demand for minimally invasive procedures. These companies are actively collaborating with healthcare institutions to drive the adoption of their advanced angiography solutions, further intensifying the competitive dynamics within the market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Hitachi Ltd.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Hologic Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 GE Healthcare
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Medtronic Plc
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Johnson & Johnson
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Philips Healthcare
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Cardinal Health Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Shimadzu Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Siemens Healthineers
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Canon Medical Systems
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Varian Medical Systems
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Baxter International Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Samsung Medison Co., Ltd.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Boston Scientific Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Fujifilm Holdings Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Angiography XR Market, By End User
    • 6.1.1 Hospitals
    • 6.1.2 Diagnostic Centers
    • 6.1.3 Research Institutes
    • 6.1.4 Others
  • 6.2 Angiography XR Market, By Indication
    • 6.2.1 Coronary Artery Disease
    • 6.2.2 Peripheral Artery Disease
    • 6.2.3 Neurovascular Disease
    • 6.2.4 Others
  • 6.3 Angiography XR Market, By Application
    • 6.3.1 Diagnosis
    • 6.3.2 Research
    • 6.3.3 Treatment
  • 6.4 Angiography XR Market, By Product Type
    • 6.4.1 Catheter Angiography
    • 6.4.2 CT Angiography
    • 6.4.3 MR Angiography
    • 6.4.4 Digital Subtraction Angiography
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Angiography XR Market by Region
  • 10.4 Latin America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 Brazil
      • 10.4.1.2 Argentina
      • 10.4.1.3 Mexico
  • 10.5 North America - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 USA
      • 10.5.1.2 Canada
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Angiography XR market is categorized based on

By Product Type

• Catheter Angiography
• CT Angiography
• MR Angiography
• Digital Subtraction Angiography
• Others

By Application

• Diagnosis
• Research
• Treatment

By End User

• Hospitals
• Diagnostic Centers
• Research Institutes
• Others

By Indication

• Coronary Artery Disease
• Peripheral Artery Disease
• Neurovascular Disease
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Canon Medical Systems
• Medtronic Plc
• Baxter International Inc.
• Cardinal Health Inc.
• Boston Scientific Corporation
• Johnson & Johnson
• Hitachi Ltd.
• Fujifilm Holdings Corporation
• Hologic Inc.
• Varian Medical Systems
• Samsung Medison Co., Ltd.
• Shimadzu Corporation